Search Results - M. Cea

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    DP092 | MOLECULAR BACKGROUND OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA RECEIVING INTENSIFIED FLUDARABINE-BASED INDUCTION: EXPLORING THE ROLE OF “SECONDARY TYPE” AND HIGH RISK MUTATION... by P. Minetto, C. Riva, E. Carminati, Y. Azzanelli, F. Puglisi, C. Nurra, G. Fugazza, A. Cagnetta, M. Cea, R.M. Lemoli

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  2. 2

    Plug and Play Modular Façade Construction System for Renovation for Residential Buildings by Jorge Torres, Roberto Garay-Martinez, Xabat Oregi, J. Ignacio Torrens-Galdiz, Amaia Uriarte-Arrien, Alessandro Pracucci, Oscar Casadei, Sara Magnani, Noemi Arroyo, Angel M. Cea

    Published in Buildings (2021-09-01)
    Get full text
    Article


  3. 3

    P539: PROGNOSTIC RELEVANCE OF MINIMAL RESIDUAL DISEASE IN THERAPY RELATED AND SECONDARY ACUTE MYELOID LEUKEMIA RECEIVING CPX-351 OR FLUDARABINE-BASED INDUCTION. by F. Guolo, P. Minetto, C. Riva, F. Parodi, M. Miglino, E. Tedone, N. Colombo, E. Carminati, C. Nurra, A. Cagnetta, M. Cea, R. M. Lemoli

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  4. 4

    DP091 | EFFICACY OF CPX-351 IN SECONDARY ACUTE MYELOID LEUKEMIA DEFINED ACCORDING TO WHO 2022 CLASSIFICATION. by F. Guolo, C. Riva, S. Nicoletta, R. Romei, G. Zecchetti, E. Maio, Y. Azzanelli, N. Colombo, S. Rosellini, A. Parodi, E. Tedone, E. Carminati, F. Puglisi, C. Nurra, G. Fugazza, P. Nozza, M. Cea, R.M. Lemoli

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  5. 5

    DP031 | PROGNOSTIC IMPACT OF HIGH-RISK MUTATIONS IN SECONDARY AML TREATED WITH CPX-351: A FOCUS ON MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL by C. Riva, P. Minetto, S. Nicoletta, R. Romei, M. Chies, G. Zecchetti, E. Maio, Y. Azzanelli, N. Colombo, S. Rosellini, A. Parodi, E. Tedone, E. Carminati, F. Puglisi, C. Nurra, G. Fugazza, P. Nozza, M. Cea, R.M. Lemoli, F. Guolo

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  6. 6

    P49 A REAL-WORLD RETROSPECTIVE-PROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF COMBINED IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE NORTHER... by A. Furlan, M. Cea, R. Zambello, L. Pavan, M Galli, C. Clissa, S. Mangiacavalli, A. Cafro, S. Girlanda, F. Patriarca, C. Minotto, G. Bertoldero, G. Barilà, A. Pascarella, A. Lico, R. Paolini, N. Rabassi, N. Pescosta, M. Porrazzo, G. De Sabbata, A. Pompa, G. Bega, S. Cavallin, F. Guidotti, G. Semenzato, C. Zaina, F. Gherlinzoni

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  7. 7

    C061 | CARFILZOMIB INDUCTION, CONSOLIDATION, AND MAINTENANCE WITH OR WITHOUT AUTOLOGOUS STEM-CELL TRANSPLANT: LONG-TERM FOLLOW-UP OF THE RANDOMISED, PHASE 2 FORTE TRIAL by F. Gay, G. Bertuglia, D. Rota-Scalabrini, A. Belotti, L. Paris, M. Cea, F. Patriarca, M. D'agostino, M. Gentile, M. Luppi, G. De Sabbata, S. Palmieri, G. Pietrantuono, A.M. Liberati, R. Bassan, F. Monaco, P. Tosi, O. Annibali, F. Pisani, P. Galieni, N. Pescosta, L. De Rosa, R. Zambello, M.T. Petrucci, P. Corradini, M. Offidani, B. Bruno, M. Boccadoro, E. Zamagni, P. Musto

    Published in Haematologica (2025-09-01)
    Get full text
    Article


Search Tools: